Results: 1-25 | 26-50 | 51-75 | 76-81
Results: 1-25/81

Authors: Cannon, CP Battler, A Brindis, RG Cox, JL Ellis, SG Every, NR Flaherty, JT Harrington, RA Krumholz, HM Simoons, ML Van de Werf, FJJ Weintraub, WS Mitchell, KR Morrisson, SL Brandis, RG Anderson, HV Cannom, DS Chitwood, WR Cigarroa, JE Collins-Nakai, RL Ellis, SG Gibbons, RJ Grover, FL Heidenreich, PA Khandheria, BK Knoebel, SB Krumholz, HL Malenka, DJ Mark, DB McKay, CR Passamani, ER Radford, MJ Riner, RN Schwartz, JB Shaw, RE Shemin, RJ Van Fossen, DB Verrier, ED Watkins, MW Phoubandith, DR Furnelli, T
Citation: Cp. Cannon et al., American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee), J AM COL C, 38(7), 2001, pp. 2114-2130

Authors: Morrow, DA Cannon, CP Rifai, N Frey, MJ Vicari, R Lakkis, N Robertson, DH Hille, DA DeLucca, PT DiBattiste, PM Demopoulos, LA Weintraub, WS Braunwald, E
Citation: Da. Morrow et al., Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial, J AM MED A, 286(19), 2001, pp. 2405-2412

Authors: Morrow, DA Antman, EM Parsons, L de Lemos, JA Cannon, CP Giugliano, RP McCabe, CH Barron, HV Braunwald, E
Citation: Da. Morrow et al., Application of the TIMI risk score for ST-Elevation MI in the National Registry of Myocardial Infarction 3, J AM MED A, 286(11), 2001, pp. 1356-1359

Authors: Cannon, CP Braunwald, E
Citation: Cp. Cannon et E. Braunwald, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes - Reply, N ENG J MED, 345(21), 2001, pp. 1574-1575

Authors: de Lemos, JA Morrow, DA Bentley, JH Omland, T Sabatine, MS McCabe, CH Hall, C Cannon, CP Braunwald, E
Citation: Ja. De Lemos et al., The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes, N ENG J MED, 345(14), 2001, pp. 1014-1021

Authors: Cannon, CP Weintraub, WS Demopoulos, LA Vicari, R Frey, MJ Lakkis, N Neumann, FJ Robertson, DH DeLucca, PT DiBattiste, PM Gibson, CM Braunwald, E
Citation: Cp. Cannon et al., Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban., N ENG J MED, 344(25), 2001, pp. 1879-1887

Authors: Ohman, EM Harrington, RA Cannon, CP Agnelli, G Cairns, JA Kennedy, JW
Citation: Em. Ohman et al., Intravenous thrombolysis in acute myocardial infarction, CHEST, 119(1), 2001, pp. 253S-277S

Authors: Cannon, CP Nelson, SD Panosian, CB Seeger, LL Eilber, FR Eckardt, JJ
Citation: Cp. Cannon et al., Soft tissue echinococcosis - A report of two cases and review of the literature, CLIN ORTHOP, (385), 2001, pp. 186-191

Authors: Cannon, CP
Citation: Cp. Cannon, Importance of TIMI 3 flow, CIRCULATION, 104(6), 2001, pp. 624-626

Authors: Gibson, CM de Lemos, JA Murphy, SA Marble, SJ McCabe, CH Cannon, CP Antman, EM Braunwald, E
Citation: Cm. Gibson et al., Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction - A TIMI 14 substudy, CIRCULATION, 103(21), 2001, pp. 2550-2554

Authors: O'Connor, FF Shields, DC Fitzgerald, A Cannon, CP Braunwald, E Fitzgerald, DJ
Citation: Ff. O'Connor et al., Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes, BLOOD, 98(12), 2001, pp. 3256-3260

Authors: O'Rourke, RA Hochman, JS Cohen, MC Lucore, CL Popma, JJ Cannon, CP
Citation: Ra. O'Rourke et al., New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction, ARCH IN MED, 161(5), 2001, pp. 674-682

Authors: Kloner, RA Das, S Poole, WK Perrit, R Muller, J Cannon, CP Braunwald, E
Citation: Ra. Kloner et al., Seasonal variation of myocardial infarct size, AM J CARD, 88(9), 2001, pp. 1021

Authors: Schweiger, MJ Cannon, CP Murphy, SA Gibson, CM Cook, JR Giugliano, RP Changezi, HU Antman, EM Braunwald, E
Citation: Mj. Schweiger et al., Early coronary intervention following pharmacologic therapy for acute myocardial infarction - (The combined TIMI 10B-TIMI 14 experience), AM J CARD, 88(8), 2001, pp. 831-836

Authors: Bray, PF Cannon, CP Goldschmidt-Clermont, P Moye, LA Pfeffer, MA Sacks, FM Braunwald, E
Citation: Pf. Bray et al., The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction, AM J CARD, 88(4), 2001, pp. 347-352

Authors: de Lemos, JA Morrow, DA Gibson, CM Murphy, SA Rifai, N Tanasijevic, M Giugliano, RP Schuhwerk, KC McCabe, CH Cannon, CP Antman, EM Braunwald, E
Citation: Ja. De Lemos et al., Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy, AM J CARD, 88(4), 2001, pp. 353-358

Authors: Cannon, CP McCabe, CH Wilcox, RG Bentley, JH Braunwald, E
Citation: Cp. Cannon et al., Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris, AM J CARD, 87(5), 2001, pp. 636-639

Authors: Gibson, CM Murphy, SA Marble, SJ McCabe, CH Antman, EM Cannon, CP Braunwald, E
Citation: Cm. Gibson et al., Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytictrials?, AM J CARD, 87(4), 2001, pp. 450

Authors: Srinivas, VS Cannon, CP Gibson, CM Antman, EM Greenberg, MA Tanasijevic, MJ Murphy, S de Lemos, JA Sokol, S Braunwald, E Mueller, HS
Citation: Vs. Srinivas et al., Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A thrombolysis in myocardial infarction 10B substudy, AM HEART J, 142(1), 2001, pp. 29-36

Authors: Giugliano, RP McCabe, CH Antman, EM Cannon, CP Van de Werf, F Wilcox, RG Braunwald, E
Citation: Rp. Giugliano et al., Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage, AM HEART J, 141(5), 2001, pp. 742-750

Authors: Agnelli, G Avezum, A Brieger, D Budaj, A Cannon, CP Goldberg, RJ Goodman, S Gulba, DC Granger, C Kennelly, BM Gurfinkel, E Lopez-Sendon, J Klein, W Montalescot, G Van de Werf, F
Citation: G. Agnelli et al., Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes, AM HEART J, 141(2), 2001, pp. 190-199

Authors: Wang-Clow, F Lynn, N Cannon, CP Gibson, M Berioli, S Bluhmki, E Danays, T Braunwald, E Van De Werf, F Stump, DC
Citation: F. Wang-clow et al., Determination of a weight-adjusted dose of TNK-tissue plasminogen activator, AM HEART J, 141(1), 2001, pp. 33-40

Authors: Richards, CF Cannon, CP
Citation: Cf. Richards et Cp. Cannon, Reducing medication errors: Potential benefits of bolus thrombolytic agents, ACAD EM MED, 7(11), 2000, pp. 1285-1289

Authors: Cannon, CP
Citation: Cp. Cannon, Bridging the gap with new strategies in acute ST elevation myocardial infarction: Bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI, J THROMB TH, 9(3), 2000, pp. 235-241

Authors: Cannon, CP Sayah, AJ Walls, RM
Citation: Cp. Cannon et al., ER TIMI-19: Testing the reality of prehospital thrombolysis, J EMERG MED, 19(3), 2000, pp. 21S-25S
Risultati: 1-25 | 26-50 | 51-75 | 76-81